---
{"dg-publish":true,"permalink":"/USMLE/Immunology/Chronic granulomatous disease/"}
---

Definition: deficiency of superoxide production by polymorphonuclear neutrophils and macrophages
# Etiology
X-linked recessive or autosomal recessive inheritance (2:1)

---
# Pathophysiology
![Pasted image 20240404105126.png](/img/user/appendix/Pasted%20image%2020240404105126.png)
<span style="background:rgba(240, 200, 0, 0.2)">Defective phagocytic nicotinamide adenine dinucleotide phosphate (NADPH) oxidase</span> that results in:
- Impaired respiratory burst & ↓ reactive oxygen species → <span style="background:rgba(240, 200, 0, 0.2)">inhibition of phagocytic intracellular killing</span>

---
# Clinical features
- Recurrent, severe infections (chronic skin, lymph node, bone, respiratory, GI, and [[USMLE/Renal/Urinary tract infections\|urinary tract infections]]) with <span style="background:rgba(240, 200, 0, 0.2)">catalase-positive organisms</span>
	- <span style="background:rgba(240, 200, 0, 0.2)">[[USMLE/Infective disease/Staphylococcus aureus\|Staphylococcus aureus]]</span>
	- <span style="background:rgba(240, 200, 0, 0.2)">Burkholderia cepacia</span>
	- Serratia marcescens
	- [[USMLE/Infective disease/Nocardiosis\|Nocardia]]
	- <span style="background:rgba(240, 200, 0, 0.2)">[[USMLE/Respiratory/Aspergillosis\|Aspergillus]]</span>
- [[USMLE/Pathology/Lymphadenopathy\|Lymphadenopathy]]
- Granulomas of the skin and GI/GU tract

---
# Diagnostics
- Neutrophil assay
	- <span style="background:rgba(240, 200, 0, 0.2)">Dihydrorhodamine test (DHR): flow cytometry test showing abnormal NADPH oxidase activity</span> (inability to metabolize dihydrorhodamine to fluorescent product, rhodamine → <span style="background:rgba(240, 200, 0, 0.2)">decreased green fluorescence</span>)
		- The DHR assay detects the conversion of DHR (a colorless substance) to rhodamine (fluoresces green) by free radicals produced when the NADPH oxidase pathway is stimulated (eg, by a protein kinase C agonist such as phorbol myristate acetate).  In unaffected patients, stimulated cells show increased intensity of fluorescence (ie, rightward shift along the x-axis), indicating appropriate NADPH activity, whereas unstimulated cells remain colorless.  In patients with CGD, the stimulated cells show no increased fluorescence (ie, no oxidation of DHR).![highresdefault_L77221.png](/img/user/appendix/highresdefault_L77221.png)
 - Nitroblue tetrazolium dye reduction test: negative

---
# Treatment
- Life-long prophylactic [[USMLE/Pharmacology/Antibiotics\|antibiotics]], e.g., TMP-SMX (for catalase-positive infections)
- [[USMLE/Biochemistry/Interferons and Tumor necrosis factor\|IFN-γ]] therapy
- Bone marrow transplant

---
